Table 2 Probe evaluation in relation to pathology
Pt # | Probe evaluation | Pathologic evaluation | |||||||
|---|---|---|---|---|---|---|---|---|---|
Injected activity [MBq] | Total activity left at time of scanning [MBq] and injection-surgery time interval [min] | S/B prostate tumor* | S/B PET positive LNs | Extra-capsular tumor spread | Positive resection margins | Shortest tumor-border distance [mm] | Tumor in PET Positive LNs | Tumor stage | |
1 | 68 | 11 (180) | 107/14 = 7.6 | N.A. | Yes | Yes | 0 | N.A. | pT3aN0 R1 |
2 | 88 | 15 (170) | 40/16 = 2.5 | N.A. | No | No | > 3 | N.A. | pT2N0 R0 |
3 | 76 | 13 (175) | 108/15 = 7.2 | 50/8 = 6.3 (ExR), 34/10 = 3.4 (ObR) | Yes | No | < 1 | Yes (ExR), no (ObR) | pT3bN1 R0 |
4 | 97 | 32 (110) | 88/40 = 2.2 | N.A. | Yes | No | > 1.5 | N.A. | pT3bN0 R0 |
5 | 65 | 14 (150) | 108/15 = 7.2 | N.A. | No | No | < 0.5 | N.A. | pT2N0 R0 |
6 | 62 | 18 (120) | 247/45 = 5.5 | N.A. | Yes | No | < 0.5 | N.A. | pT3aN1 R0 |
7 | 23 | 7 (120) | 35/7 = 5.0 | 20/3 = 6.7 (ObL), 9/3 = 3.0 (ExR) | Yes | Yes | 0 | Yes(ObL), yes (ExR) | pT3bN1 R1 |